Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)

ClinicalTrials.gov ID: NCT02497001

Public ClinicalTrials.gov record NCT02497001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® as an Active Control in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease.

Study identification

NCT ID
NCT02497001
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pearl Therapeutics, Inc.
Industry
Enrollment
1,902 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2015 (Actual)
Primary completion
Jan 5, 2018 (Actual)
Completion
Jan 5, 2018 (Actual)
Last update posted
Dec 24, 2020

2015 – 2018

United States locations

U.S. sites
63
U.S. states
18
U.S. cities
57
Facility City State ZIP Site status
Research Site Andalusia Alabama 36420 —
Research Site Jasper Alabama 35501 —
Research Site Peoria Arizona 85381 —
Research Site Phoenix Arizona 85018 —
Research Site Fullerton California 92835 —
Research Site Gold River California 95670 —
Research Site Poway California 92064 —
Research Site Rolling Hills Estates California 90274 —
Research Site Sacramento California 95821 —
Research Site Clearwater Florida 33756 —
Research Site Miami Florida 33175 —
Research Site Miami Florida 33186 —
Research Site Ormond Beach Florida 32174 —
Research Site Pensacola Florida 32503 —
Research Site Tamarac Florida 33321 —
Research Site Tampa Florida 33603 —
Research Site Winter Park Florida 32789 —
Research Site Dacula Georgia 30019 —
Research Site Norcross Georgia 30071 —
Research Site Rincon Georgia 31326 —
Research Site Edina Minnesota 55435 —
Research Site Minneapolis Minnesota 55402 —
Research Site Minneapolis Minnesota 55407 —
Research Site Woodbury Minnesota 55125 —
Research Site Saint Charles Missouri 63301 —
Research Site St Louis Missouri 63141 —
Research Site Reno Nevada 89503 —
Research Site Albuquerque New Mexico 87108 —
Research Site Charlotte North Carolina 28207 —
Research Site Gastonia North Carolina 28054 —
Research Site Greensboro North Carolina 27408 —
Research Site Hendersonville North Carolina 28739 —
Research Site Mooresville North Carolina 28117 —
Research Site Wilmington North Carolina 28401 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45231 —
Research Site Cincinnati Ohio 45242 —
Research Site Cincinnati Ohio 45245 —
Research Site Columbus Ohio 43213 —
Research Site Columbus Ohio 43235 —
Research Site Dayton Ohio 45459 —
Research Site Dublin Ohio 43016 —
Research Site Medford Oregon 97504 —
Research Site Anderson South Carolina 29621 —
Research Site Charleston South Carolina 29406 —
Research Site Easley South Carolina 29640 —
Research Site Greenville South Carolina 29615 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Old Point Station South Carolina 29707 —
Research Site Rock Hill South Carolina 29732 —
Research Site Seneca South Carolina 29678 —
Research Site Spartanburg South Carolina 29303 —
Research Site Union South Carolina 29379 —
Research Site Johnson City Tennessee 37601 —
Research Site Kingwood Texas 77339 —
Research Site Longview Texas 75605 —
Research Site San Antonio Texas 78229 —
Research Site Abingdon Virginia 24210 —
Research Site Newport News Virginia 23606 —
Research Site Richmond Virginia 23225 —
Research Site Richmond Virginia 23229 —
Research Site Tacoma Washington 98405 —
Research Site Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02497001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 24, 2020 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02497001 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →